Chi siamo

I Programmi VEQ sono organizzati dal Centro Nazionale Sangue (CNS) in collaborazione con il Centro Nazionale per il Controllo e la Valutazione dei Farmaci (CNCF) dell’Istituto Superiore di Sanità (ISS).

Responsabili scientifici dei Programmi VEQ sono il Dott. Giulio Pisani (biologo, ricercatore, CNCF) e la Dott.ssa Simonetta Pupella (medico, responsabile Area Tecnico Sanitaria, CNS).

Coordinatori dei Programmi VEQ sono il Dott. Matteo Simeoni (biotecnologo, ricercatore, CNCF) e la Dott.ssa Ilaria Pati (biologa, responsabile del Settore Sorveglianza epidemiologica dei donatori di sangue, CNS).

Se desideri ricevere maggiori informazioni sui Programmi VEQ, contattaci via e-mail agli indirizzi:

Per lo schema VEQ nei saggi NAT e per lo schema VEQ nei test immunometrici: matteo.simeoni@iss.it; ilaria.pati@iss.it.

Who we are

EQA Programmes are organized by the National Blood Center (CNS) in collaboration with the National Centre for the Control and Evaluation of Medicines (CNCF) of the Istituto Superiore di Sanità (ISS).

The Scientific Directors of the EQA Programs are Dr. Giulio Pisani (biologist, researcher, CNCF) and Dr. Simonetta Pupella (physician, responsible of the Transfusion Safety Area, CNS).

The Coordinators of EQA Programmes are Dr. Matteo Simeoni (biotechnologist, researcher, CNCF) and Dr. Ilaria Pati (biologist, responsible of the Epidemiological Surveillance Sector for blood donors, CNS).

If you want to receive more information about EQA Programmes, please contact us by e-mail at the addresses:

For EQA scheme in NAT assays and EQA scheme in immunometric assays: matteo.simeoni@iss.it; ilaria.pati@iss.it.

Pubblicazioni/Publications

Pisani, Pupella S, K. Cristiano, et al. Detection of West Nile virus RNA (lineages 1 and 2) in an external quality assessment programme for laboratories screening blood and blood components for West Nile virus by nucleic acid amplification testing. Blood Transfusion 2012;10(4):515-520.

Pisani, S. Pupella, F. Marino, et al. Interlaboratory study to evaluate the performance of laboratories involved in West Nile virus RNA screening of blood and blood components by nucleic acid amplification testing in Italy. Blood Transfusion 2011;9:425-9.

Pisani, K. Cristiano, F. Marino, et al. External Quality Assessment Programmes for Detection of HCV RNA, HIV RNA and HBV DNA in Plasma: Improved Proficiency of the participants observed over a two year-period Vox Sanguinis 2010, 99(4):319-24.

Pisani, F. Marino, K. Cristiano, et al. External quality assessment for the detection of HCV RNA, HIV RNA and HBV DNA in plasma by nucleic acid amplification technology:a novel approach Vox Sanguinis 2008, 95:8-12.

Gentili, G. Pisani, J. Saldanha, et al. High proficiency in detecting the six major hepatitis C virus genotypes of laboratories involved in testing plasma by nucleic acid amplification technology Vox Sanguinis 2003, 85: 114-116.

Pisani, K. Cristiano, M. Wirz, et al. Further evidence on the high proficiency of laboratories involved in plasma pool testing for HCV RNA by nucleic acid amplification technology Vox Sanguinis 2002, 82:211-212.

Gentili, G. Pisani, G. Bisso, et al. Hepatitis C virus testing of plasma pools by nucleic acid amplification technology: external quality assessment Vox Sanguinis 2001, 81:143-147.